Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer– A Brief Report From the CROWN Study
JTO Clinical and Research Reports(2024)
Key words
Anaplastic lymphoma kinase,Japan,lorlatinib,non-small cell lung cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined